Is PBLA or JEPQ a better dividend investment in 2026?

PBLA currently yields 1000000.00% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: PBLA offers higher current income.

What is the dividend yield difference between PBLA and JEPQ?

PBLA has a forward dividend yield of 1000000.00% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 999988.90 percentage points.

Home › Compare › PBLA vs JEPQ

PBLA vs JEPQ: Dividend Comparison 2026

PBLA yields 1000000.00% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PBLA wins by $4.7683925249533696e+36M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PBLA

● Live price

1000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.7683925249533696e+36M

Annual income

$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00

Full PBLA calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — PBLA vs JEPQ

📍 PBLA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PBLA	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PBLA + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PBLA pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PBLA

Annual income on $10K today (after 15% tax)

$85,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, PBLA beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PBLA + JEPQ for your $10,000?

PBLA: 50%JEPQ: 50%

100% JEPQ50/50100% PBLA

Portfolio after 10yr

$2.3841962624766848e+36M

Annual income

$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.98%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on PBLA right now

PBLA

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-60.8

Piotroski

4/9

JEPQ

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PBLA buys

JEPQ buys

No recent congressional trades found for PBLA or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPBLAJEPQ

Forward yield	1000000.00% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4.7683925249533696e+36M	$44.8K ✓
Annual income after 10y	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00 ✓	$2,152.59
Total dividends collected	$4.7683311610149396e+36M	$16.3K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: PBLA vs JEPQ ($10,000, DRIP)

Year	PBLA Portfolio	PBLA Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$100,010,700	$100,000,000.00	$11,930	$1,110.39	+$100.00M → PBLA
2	$934,786,450,701	$934,679,439,252.34	$14,133	$1,224.34	+$934786.44M → PBLA
3	$8,165,787,108,578,292	$8,164,786,887,076,042.00	$16,632	$1,340.46	+$8165787108.56M → PBLA
4	$66,665,884,190,957,650,000	$66,657,146,798,751,470,000.00	$19,454	$1,457.97	+$66665884190957.63M → PBLA
5	$508,662,171,058,048,100,000,000	$508,590,838,561,963,700,000,000.00	$22,626	$1,576.08	+$508662171058048128.00M → PBLA
6	$3,627,235,248,428,489,700,000,000,000	$3,626,690,979,905,457,600,000,000,000.00	$26,175	$1,694.09	+$3.62723524842849e+21M → PBLA
7	$24,173,681,159,150,610,000,000,000,000,000	$24,169,800,017,434,790,000,000,000,000,000.00	$30,133	$1,811.32	+$2.417368115915061e+25M → PBLA
8	$150,567,402,861,454,640,000,000,000,000,000,000	$150,541,537,022,614,370,000,000,000,000,000,000.00	$34,531	$1,927.17	+$1.5056740286145463e+29M → PBLA
9	$876,477,100,281,847,600,000,000,000,000,000,000,000	$876,315,993,160,785,800,000,000,000,000,000,000,000.00	$39,403	$2,041.08	+$8.764771002818475e+32M → PBLA
10	$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000	$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00	$44,787	$2,152.59	+$4.7683925249533696e+36M → PBLA

PBLA vs JEPQ: Complete Analysis 2026

PBLA — Stock

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.

Full PBLA Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this PBLA vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PBLA vs SCHD PBLA vs JEPI PBLA vs O PBLA vs KO PBLA vs MAIN PBLA vs XYLD PBLA vs QYLD PBLA vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.